BOOST Pharma Will Present BT-101 Data in October
The clinical-stage firm will discuss its allogeneic stem cell therapy for osteogenesis imperfecta in Phoenix.
Live Poll
Is now a good time to invest in early-stage medical companies ahead of final clinical trials?